Aclaris Therapeutics (ACRS) Other Non Operating Income (2016 - 2024)

Aclaris Therapeutics' Other Non Operating Income history runs 9 years deep, the most recent figure standing at $1.9 million for Q2 2024.

• In Q2 2024, Other Non Operating Income fell 16.83% year-over-year to $1.9 million; the TTM figure through Jun 2024 stood at $8.4 million (up 31.29% YoY), while the FY2023 annual figure was $8.5 million, up 188.83% from the prior year.
• Other Non Operating Income for Q2 2024 stood at $1.9 million, down from $2.0 million in the prior quarter.
• The five-year high for Other Non Operating Income was $2.3 million in Q3 2023, with the low at -$851000.0 in Q3 2021.
• The 5-year median for Other Non Operating Income is $320000.0 (2020), against an average of $763722.2.
• The sharpest annual moves came in 2021 and 2022: Other Non Operating Income slumped 338.66% in 2021, then soared 1522.47% in 2022.
• Aclaris Therapeutics' Other Non Operating Income stood at -$219000.0 in 2020, then soared by 140.64% to $89000.0 in 2021, then surged by 1522.47% to $1.4 million in 2022, then surged by 51.59% to $2.2 million in 2023, then decreased by 14.66% to $1.9 million in 2024.
• Business Quant data shows ACRS's Other Non Operating Income at $1.9 million in Q2 2024, $2.0 million in Q1 2024, and $2.2 million in Q4 2023.